Tag Archives: Washington Post

5 Arguments from the GMO Debate That Have Lost Their Gusto

GMO Debate

The Washington Post recently published a piece titled The GMO Debate: 5 Things to Stop Arguing, which looks at common arguments surrounding the use of genetically modified organism (GMOs) and how they have lost their vigor.  Specifically in her article, Tamar Haspel suggests 5 somethings taken from both sides of the debate that need to be retired. Haspel argues that moving beyond these 5 points could mean moving one step forward in achieving a happy medium between the two parties. 1. GMOs are Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Breast Cancer

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide ‘substantially much higher health benefits than the traditional drugs.’ “Our study suggests that although specialty drugs often have higher costs than traditional drugs, they also tend to confer greater benefits and hence may still offer reasonable value for money,” wrote the researchers at the Boston-based Center for Value and Risk in Health. The study authors judged the drugs’ performance by Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , ,

Washington Post: GM Crops can “Improve the Lives of Millions”

drought-corn-CBI

Many anti-GMO advocates cite their opposition to the technology because they see agribusiness focused mainly on making a profit However, “the application of current biotechnological tools to agriculture offers a wide array of benefits, benefits that are only beginning to be seen,” according to the editorial board at the Washington Post. In a recent editorial, titled “Genetically Modified Crops Could Help Improve the Lives of Millions”, the editors of the Washington Post argued how consumers Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

Washington Post: Crowdsourcing Medical Decisions

clinical-trial-article-115x76

On Monday, Ariana Eunjung Cha wrote about the difficult ethical issue of Compassionate Use, which allows a patient access to an unapproved treatment when others with similar requests are denied access. Arthur Caplan, director of the division of medical ethics at New York University’s Langone Medical Center, describes it as a moral dilemma that could not be ‘more troubling and impossible-to-resolve’. In the article, Caplan asserts that ‘it’s best for the company to focus on getting the Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , ,

Quandary for U.S. companies: Whom to bribe? (Washington Post)

WV3Cover

From this Sunday’s Washington Post, David Hilzenrath lays out ambiguities of the Foreign Corrupt Practices Act. Scientific American’s Worldview 2011 report compares corruption among countries seeking to grow the biotech industry within their borders based on the 2010 Corruption Perceptions Index from Transparency International. Countries that ranked high in perceived corruption tended to rank lower in terms of overall innovation. In other words, as corruption increases, the nation’s business reputation sinks while those with a Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,